87 related articles for article (PubMed ID: 3017826)
1. Some Epstein-Barr virus-transformed B lymphoblastoid cell lines have an altered structure around the mixed lymphocyte culture-inducing domain on DR molecules.
Nagayoshi T; Morito F; Kaneoka H; Yamaguchi M
Fukuoka Igaku Zasshi; 1986 May; 77(5):287-92. PubMed ID: 3017826
[No Abstract] [Full Text] [Related]
2. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
4. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
Gallagher G; Stimson WH
Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
[TBL] [Abstract][Full Text] [Related]
6. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
Vyakarnam A; Lachmann PJ
Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
[TBL] [Abstract][Full Text] [Related]
7. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
[TBL] [Abstract][Full Text] [Related]
8. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
[No Abstract] [Full Text] [Related]
9. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
Altomonte M; Pucillo C; Damante G; Maio M
J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
[TBL] [Abstract][Full Text] [Related]
10. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
11. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
12. HLA type of EBV-transformed human B cell lines.
Hurley CK; Johnson AH
Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1G. PubMed ID: 18432643
[TBL] [Abstract][Full Text] [Related]
13. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.
Hajeer AH; Snowden N; Wilson P; Drover S; Ollier WE
Immunology; 1993 Dec; 80(4):593-7. PubMed ID: 8307609
[TBL] [Abstract][Full Text] [Related]
15. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
[TBL] [Abstract][Full Text] [Related]
16. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
17. Provision of Epstein-Barr virus-transformed B-cell lines in a routine tissue typing laboratory: practicalities and applications.
Bass H; Walters R; Darke C
Eur J Immunogenet; 2004 Apr; 31(2):87-92. PubMed ID: 15086349
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
Brown NA; Miller G
J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
[TBL] [Abstract][Full Text] [Related]
20. Antiidiotypic antibodies: production in vitro by EBV-transformed lymphoblastoid cell lines and immunochemical characterization of idiotypic receptors on T-cells.
Singal DP; Joseph S; Frame B; Ludwin D; Mervart H; Blajchman MA
Transplant Proc; 1989 Feb; 21(1 Pt 1):333-5. PubMed ID: 2539669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
